四川医学2018，Vol.39Issue(5)：590-592,3.DOI:10.16252/j.cnki.issn1004-0501-2018.05.029
18F-FDG PET/CT鉴别诊断乳腺良恶性病变的价值
Value of 18F-FDG PET/CT on Differential Dignosis of Breast Benign and Malignant Lesions
郭佳 1谢红军1
作者信息
- 1. 四川省医学科学院·四川省人民医院核医学科,四川 成都610072
- 折叠
摘要
Abstract
Objective To evaluate the value of fluorine-18 fluorodeoxyglucose positron emission tomography( 18 F-FDG PET/CT) on differential diagnosis of breast benign and malignant lesions. Methods 38 cases patients with breast masses were all performed 18 F-FDG PET/CT imaging and breast molybdenum target inspection and the diagnosis results and postoperative patho-logical results were compared and anlayzed. Results 38 patients in this group were all performed surgical and pathological exami-nation and 30 were pathologically diagnosed as malignant tumor(25 cases invasive ductal carcinoma and 4 cases invasive lobular carcinoma,1 case ductal carcinoma in situ) ,while 8 were breast benign lesions. The sensitivity、specificity、accuracy、positive pre-dictive value and negative predictive value of 18 F-FDG PET/CT in the diagnosis of breast malignant tumors were respectively 90%(27/30)、75%(6/8)、86. 8%(33/38)、93. 1%(27/29) and 66. 7%(6/9);The sensitivity、specificity、accuracy、positive predic-tive value and negative predictive value of breast molybdenum target in the diagnosis of breast malignant tumor were 70%( 21/30)、62. 5%(5/8)、68. 4%(26/38)、87. 5%(21/24)and 35. 7%(5/14). As for 18F-FDG PET/CT imaging compared with mo-lybdenum target,both had statistically significant difference on the differential diagnosis of breast benign and malignant lesions of all the above indicators(P<0. 05). Conclusion 18F-FDG PET/CT imaging for differential diagnosis of breast benign and malig-nant lesions is superior to breast molybdenum target inspection,especially for dense breast.关键词
乳腺癌/18F-FDGPET/CT/乳腺钼靶X线Key words
breast cancer/18 F-FDG PET/CT/breast molybdenum target X-ray分类
医药卫生引用本文复制引用
郭佳,谢红军..18F-FDG PET/CT鉴别诊断乳腺良恶性病变的价值[J].四川医学,2018,39(5):590-592,3.
